133 related articles for article (PubMed ID: 15592577)
1. Therapeutic potential of monteplase in acute myocardial infarction as a powerful thrombolytic agent for pretreatment of coronary intervention.
Inoue T; Nishiki R; Kageyama M; Node K
Cardiovasc Drug Rev; 2004; 22(4):320-33. PubMed ID: 15592577
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of monteplase in acute myocardial infarction.
Inoue T; Nishiki R; Kageyama M; Node K
Am J Cardiovasc Drugs; 2005; 5(4):225-31. PubMed ID: 15984905
[TBL] [Abstract][Full Text] [Related]
3. A new thrombolytic agent, monteplase, is independent of the plasminogen activator inhibitor in patients with acute myocardial infarction: initial results of the COmbining Monteplase with Angioplasty (COMA) trial.
Inoue T; Yaguchi I; Takayanagi K; Hayashi T; Morooka S; Eguchi Y
Am Heart J; 2002 Oct; 144(4):E5. PubMed ID: 12360174
[TBL] [Abstract][Full Text] [Related]
4. Long-term benefits of monteplase before coronary angioplasty in acute myocardial infarction.
Inoue T; Nishiki R; Kageyama M; Chida R; Hayashi T; Takayanagi K; Hikichi Y; Node K
Am J Cardiol; 2005 Feb; 95(4):506-8. PubMed ID: 15695140
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome of percutaneous coronary intervention with antecedent mutant t-PA administration for acute myocardial infarction.
Kurihara H; Matsumoto S; Tamura R; Yachiku K; Nakata A; Nakagawa T; Yoshino T; Matsuyama T
Am Heart J; 2004 Apr; 147(4):E14. PubMed ID: 15077097
[TBL] [Abstract][Full Text] [Related]
6. Low-dose tissue plasminogen activator followed by planned rescue angioplasty reduces time to reperfusion for acute myocardial infarction treated at community hospitals.
Kimura K; Tsukahara K; Usui T; Okuda J; Kitamura Y; Kosuge M; Sano T; Tohyama S; Yamanaka O; Yoshii Y; Umemura S
Jpn Circ J; 2001 Oct; 65(10):901-6. PubMed ID: 11665796
[TBL] [Abstract][Full Text] [Related]
7. [Usefulness of combination therapy of hybrid thrombolysis followed by back-up percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction].
Mukawa H; Sone T; Tsuboi H; Kondo J; Kosokabe T; Uesugi M; Imai H
J Cardiol; 2001 Apr; 37(4):181-9. PubMed ID: 11337927
[TBL] [Abstract][Full Text] [Related]
8. Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience).
Schweiger MJ; Cannon CP; Murphy SA; Gibson CM; Cook JR; Giugliano RP; Changezi HU; Antman EM; Braunwald E;
Am J Cardiol; 2001 Oct; 88(8):831-6. PubMed ID: 11676942
[TBL] [Abstract][Full Text] [Related]
9. [Impact of intravenous thrombolysis prior to percutaneous coronary intervention in reperfusion therapy for acute myocardial infarction].
Uto K; Ota Y; Mizuno M; Nakamura A; Nakajima R; Endoh Y; Kasanuki H
J Cardiol; 2002 Dec; 40(6):241-8. PubMed ID: 12528645
[TBL] [Abstract][Full Text] [Related]
10. The level I cardiovascular center: is it time?
Smalling RW; Giesler G
Am Heart Hosp J; 2003; 1(2):170-4. PubMed ID: 15815138
[TBL] [Abstract][Full Text] [Related]
11. Tissue-type plasminogen activator therapy versus primary coronary angioplasty: impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction.
Agati L; Voci P; Hickle P; Vizza DC; Autore C; Fedele F; Feinstein SB; Dagianti A
J Am Coll Cardiol; 1998 Feb; 31(2):338-43. PubMed ID: 9462577
[TBL] [Abstract][Full Text] [Related]
12. An early and complete reperfusion strategy for acute myocardial infarction using fibrinolysis and subsequent transluminal therapy--The FAST trial.
Nagao K; Hayashi N; Kanmatsuse K; Kikuchi S; Ohuba T; Takahashi H;
Circ J; 2002 Jun; 66(6):576-82. PubMed ID: 12074277
[TBL] [Abstract][Full Text] [Related]
13. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators.
Smalling RW; Bode C; Kalbfleisch J; Sen S; Limbourg P; Forycki F; Habib G; Feldman R; Hohnloser S; Seals A
Circulation; 1995 Jun; 91(11):2725-32. PubMed ID: 7758177
[TBL] [Abstract][Full Text] [Related]
14. Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infarction. Second Primary Angioplasty in Myocardial Infarction Trial (PAMI-2) Investigators.
Stone GW; Brodie BR; Griffin JJ; Grines L; Boura J; O'Neill WW; Grines CL
J Am Coll Cardiol; 2000 Mar; 35(3):605-11. PubMed ID: 10716461
[TBL] [Abstract][Full Text] [Related]
15. Transfer for urgent percutaneous coronary intervention early after thrombolysis for ST-elevation myocardial infarction: the TRANSFER-AMI pilot feasibility study.
Cantor WJ; Burnstein J; Choi R; Heffernan M; Dzavik V; Lazzam C; Duic M; Fitchett D; Tan M; Wawrzyniak J; Kassam S; Dhingra S; Morrison LJ; Langer A; Goodman SG
Can J Cardiol; 2006 Nov; 22(13):1121-6. PubMed ID: 17102829
[TBL] [Abstract][Full Text] [Related]
16. Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial.
Jarai R; Huber K; Bogaerts K; Droogne W; Ezekowitz J; Granger CB; Sinnaeve PR; Ross AM; Zeymer U; Armstrong PW; Van de Werf FJ;
Am Heart J; 2010 Jan; 159(1):131-40. PubMed ID: 20102879
[TBL] [Abstract][Full Text] [Related]
17. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
Thiele H; Schindler K; Friedenberger J; Eitel I; Fürnau G; Grebe E; Erbs S; Linke A; Möbius-Winkler S; Kivelitz D; Schuler G
Circulation; 2008 Jul; 118(1):49-57. PubMed ID: 18559698
[TBL] [Abstract][Full Text] [Related]
18. Multicenter randomized trial of facilitated percutaneous coronary intervention with low-dose tenecteplase in patients with acute myocardial infarction: the Athens PCI trial.
Kanakakis J; Nanas JN; Tsagalou EP; Maroulidis GD; Drakos SG; Ntalianis AS; Tzoumele P; Skoumbourdis E; Charbis P; Rokas S; Anastasiou-Nana M
Catheter Cardiovasc Interv; 2009 Sep; 74(3):398-405. PubMed ID: 19360864
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy of primary angioplasty with stent implantation and thrombolysis in restoring basal coronary artery flow in acute ST segment elevation myocardial infarction: quantitative assessment using the corrected TIMI frame count.
Vrachatis AD; Alpert MA; Georgulas VP; Nikas DJ; Petropoulou EN; Lazaros GI; Michelakakis NA; Karavidis AI; Lakoumentas JA; Stergiou L; Zacharoulis AA
Angiology; 2001 Mar; 52(3):161-6. PubMed ID: 11269778
[TBL] [Abstract][Full Text] [Related]
20. The role of intravenous coronary thrombolysis for patients with acute myocardial infarction in different treatment strategies.
Kobayashi H; Takazawa K; Matsumoto C; Ooi K; Nagata T; Katou K; Yoshida M; Aiga M; Aizawa A; Takahashi E; Namatame Y; Kinou M; Yamashina A
Intern Med; 2006; 45(11):709-14. PubMed ID: 16819250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
